Actinium Pharmaceuticals (ATNM) Payables (2009 - 2026)
Actinium Pharmaceuticals (ATNM) reported Payables of $8.51 million for Q2 2026, up 10.4% from $7.71 million a year earlier and up 28.7% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Actinium Pharmaceuticals posted Payables of $7.25 million, down 4.2% from FY2024.
- Payables has a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
- By year, Payables came in at $7.57 million in FY2024 (-52.4%), $15.91 million in FY2023 (+57.0%), $10.13 million in FY2022 (+83.0%) and $5.54 million in FY2021 (-36.2%).
- The Q2 2026 figure ranks as the highest quarterly Payables since Q2 2024.
- Year over year, Payables gained in two of the last eight quarters, with an average decline of 12.4%.
- The high point for year-over-year Payables in five years was Q3 2022 (growth of 108.6%); the low point was Q4 2024 (a decline of 52.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.62 million (Q1 2026), $7.25 million (Q4 2025) and $6.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | 8.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.51 Mn |
| Mar 31, 2026 | 6.62 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 6.22 Mn |
| Jun 30, 2025 | 7.71 Mn |
| Mar 31, 2025 | 6.52 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Mar 31, 2024 | 15.03 Mn |
| Dec 31, 2023 | 15.91 Mn |
| Sep 30, 2023 | 16.30 Mn |
| Jun 30, 2023 | 17.27 Mn |
| Mar 31, 2023 | 14.72 Mn |
| Dec 31, 2022 | 20.26 Mn |
| Sep 30, 2022 | 15.74 Mn |
| Jun 30, 2022 | 11.53 Mn |
| Mar 31, 2022 | 10.52 Mn |
| Dec 31, 2021 | 11.07 Mn |
| Sep 30, 2021 | 7.55 Mn |
API Access
Actinium Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();